Philosophy, in particular, helps students grapple with complexity, see from multiple perspectives, and cultivate intellectual ...

South Korean President Lee Jae-myung recently quipped in Washington that he looked forward to Donald Trump’s next meeting ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...

Opinion: DHA's decision to end the coverage violates the Pentagon's own regulations regarding Tricare for Life beneficiaries.

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 ...

Ohio is facing a class action lawsuit in response to a program using citizens’ unclaimed funds to pay for stadiums and other ...

DURHAM, N.C. -- On a beautiful North Carolina campus, an ACC school is heavily investing in trying to elevate its football program. No, we aren't talking about UNC's grand Bill Belichick experiment.

Half-life of approximately 100 days increases likelihood of once-per-year dosing Pharmacokinetic profile supports the ability ...

Arch acquires a new CKD platform that has the potential to produce next-generation CKD drugs for the pharmaceutical industryBased on a novel ...

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1Filing based on four Phase 3 studies that met all primary and co-primary endpoints. Th ...

Allschwil, Switzerland - September 10, 2025Idorsia Ltd (SIX: IDIA) shares new analyses of daridorexant for patients with insomnia and further characterizes insomnia disorder at World Sleep 2025, deliv ...

Sedgeley speaks in an upbeat tone when reflecting on everything from the state of wolf reintroduction in Colorado to his side ...